Skip to main content

1 Result(s)

within Bjoern Hartmann Remove this filter

and

  1. Article

    Open Access

    Reanalysis of the Rituximab in ANCA-Associated Vasculitis trial identifies granulocyte subsets as a novel early marker of successful treatment

    In the present study, we sought to identify markers in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) that distinguish those achieving remission at 6 months following rit...

    Mazen Nasrallah, Yannick Pouliot, Bjoern Hartmann… in Arthritis Research & Therapy (2015)

    Download PDF (2273 KB) View Article